NMPA Approval

Allisartan Isoproxil and Indapamide Sustained-release Tablets

Approval Number

国药准字H20250028

Company深圳信立泰药业股份有限公司

Registration Date

May 27, 2025

Drug Information

Generic Name

阿利沙坦酯吲达帕胺缓释片

Dosage Form

片剂

Strength

每片含阿利沙坦酯240mg与吲达帕胺1.5mg

Drug Type

化学药品

Registration Date

May 27, 2025

Company Information

Applicant Company

Company Name深圳信立泰药业股份有限公司

Company Address

深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区

Manufacturing Company

Company Name深圳信立泰药业股份有限公司

Company Address

深圳市坪山区龙田街道大工业区规划五路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

Privacy Policy
Terms & Conditions

© 2025 MedPath, Inc. All rights reserved.